I know what you mean, 2020 is very hopeful year for me too. 4 months for all of the following. PLX: FDA acceptance of BLA, Bright data (early 2021 FDA approval) CVM: Topline Phase III data read-out RDHL: Earnings, which hopefully show some kind of Talicia pick up, the new formulary addition is nice to see. PSTI: Topline Phase III Interim Data read-out on CLI & HF BCLI Phase III data and MS phase II CANF Interim RA & Psoriasis GMDA data will be nice to see but we already know they reached the primary endpoint so the rest is formality :)